NI-03

· Kangen Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NI-03, covering 2022-12-16 to 2022-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Ranging Study Evaluating Efficacy and Safety of NI-03 [Phase 1, Phase 2]